Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 111.53 Bn | 109.67 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.57 Bn | 35.83 Bn | 1.97 Bn |
| 3 | Zoetis | 33.84 Bn | 31.90 Bn | 1.62 Bn |
| 4 | United Therapeutics | 24.62 Bn | 22.47 Bn | 648.10 Mn |
| 5 | Aurora Cannabis | 17.89 Bn | 17.81 Bn | 33.43 Mn |
| 6 | Neurocrine Biosciences | 15.75 Bn | 14.43 Bn | 800.70 Mn |
| 7 | Regencell Bioscience Holdings | 13.55 Bn | 13.55 Bn | - |
| 8 | Elanco Animal Health | 10.61 Bn | 10.18 Bn | 785.00 Mn |
| 9 | HUTCHMED (China) | 10.36 Bn | 9.02 Bn | - |
| 10 | Alkermes | 6.14 Bn | 5.63 Bn | -116.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.46% |
| Dec 31, 2025 | 8.88% |
| Sep 30, 2025 | 56.20% |
| Jun 30, 2025 | 28.64% |
| Mar 31, 2025 | 175.53% |
| Dec 31, 2024 | 60.39% |
| Sep 30, 2024 | 34.07% |
| Jun 30, 2024 | -525.20% |
| Mar 31, 2024 | 264.94% |
| Dec 31, 2023 | 69.57% |
| Sep 30, 2023 | 67.63% |
| Jun 30, 2023 | -55.68% |
| Mar 31, 2023 | 52.82% |
| Dec 31, 2022 | -209.75% |
| Sep 30, 2022 | 35.73% |
| Jun 30, 2022 | 43.41% |
| Mar 31, 2022 | -69.11% |
| Dec 31, 2021 | -64.75% |
| Sep 30, 2021 | 12.74% |
| Jun 30, 2021 | 12.99% |
| Mar 31, 2021 | -695.33% |
| Dec 31, 2020 | 103.45% |
| Sep 30, 2020 | -3,206.43% |
| Jun 30, 2020 | 102.90% |
| Mar 31, 2020 | -37.27% |
| Dec 31, 2019 | 135.03% |
| Sep 30, 2019 | 54.43% |
| Jun 30, 2019 | -556.19% |
| Mar 31, 2019 | 96.43% |
| Dec 31, 2018 | -976.92% |
| Sep 30, 2018 | -13.28% |
| Jun 30, 2018 | -122.84% |
| Mar 31, 2018 | 109.09% |
| Dec 31, 2017 | -2,288.68% |
| Sep 30, 2017 | 108.78% |
| Jun 30, 2017 | -1,140.52% |
| Mar 31, 2017 | 155.88% |
| Dec 31, 2016 | -100.00% |
| Sep 30, 2016 | 85.11% |
| Jun 30, 2016 | 32,982,356.14% |
| Mar 31, 2016 | 17.53% |
| Dec 31, 2015 | 370.87% |
| Sep 30, 2015 | -80.89% |
| Jun 30, 2015 | 20.85% |
| Mar 31, 2015 | -35.08% |
| Dec 31, 2014 | -30.68% |
| Sep 30, 2014 | 24.19% |
| Jun 30, 2014 | -13.64% |
| Mar 31, 2014 | 114.88% |
| Dec 31, 2013 | -33.33% |
| Sep 30, 2013 | 217.70% |
| Jun 30, 2013 | -174.15% |
| Mar 31, 2013 | 278.97% |
| Dec 31, 2012 | 191.12% |
| Sep 30, 2012 | -129.36% |
| Jun 30, 2012 | 1.53% |
| Mar 31, 2012 | 90.96% |
| Dec 31, 2011 | -56.23% |
| Sep 30, 2011 | 63.00% |
| Jun 30, 2011 | -26.81% |
| Mar 31, 2011 | -0.69% |
| Dec 31, 2010 | -28.50% |
| Sep 30, 2010 | 31.01% |
| Jun 30, 2010 | 12.34% |
| Mar 31, 2010 | 94.08% |
| Dec 31, 2009 | -42.28% |
| Sep 30, 2009 | 21.06% |
| Jun 30, 2009 | 103.24% |